RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

about

Associations of sirtuins with clinicopathological parameters and prognosis in non-small cell lung cancer

P2860

Q58754540-0660ECF1-1B30-4D8D-9830-FA373FC145AA

P2860

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

Item

http://www.wikidata.org/entity/Q49246677

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@en

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@nl

type

Item

label

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@en

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@nl

prefLabel

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@en

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@nl

P1476

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

@en

P2093

Fengling Liu

http://www.w3.org/2001/XMLSchema#string

Qiang Wang

http://www.w3.org/2001/XMLSchema#string

Tao Chen

http://www.w3.org/2001/XMLSchema#string

Zhaojun Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt

The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis

Advances in adjuvant systemic therapy for non-small-cell lung cancer.

RASSF1A promotes apoptosis and suppresses the proliferation of ovarian cancer cells.

The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun.

Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients.

The SARAH Domain of RASSF1A and Its Tumor Suppressor Function

SIRT6 Depletion Suppresses Tumor Growth by Promoting Cellular Senescence Induced by DNA Damage in HCC.

SIRT6 deacetylates PKM2 to suppress its nuclear localization and oncogenic functions.

Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.

P304

5759-5764

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6172

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29204192

http://www.w3.org/2001/XMLSchema#string

P932

5707562

http://www.w3.org/2001/XMLSchema#string

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

about

P2860

P2860

RASSF1A and SIRT6 in non-small cell lung cancer: Relationship with clinical outcome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932